HYPR Company Profile and Key Details

Hyperfine, Inc. generated EPS of -$0.52 over the past year. Five-year average earnings growth is 11.81%. The latest quarter delivered EPS of -$0.11. The next quarter is forecast at -$0.08. Next year's EPS is expected at $2.56. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $2.00 to $0.85. The high target offers 83.49% upside. The low target suggests -22.02% downside. The mean target is $1.31. This offers 20.18% upside. Hyperfine, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 13, 2025, missed forecasts by 10.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in August 08, 2024.

HYPR has shown mixed momentum, gaining 17.65% over the past week and -7.69% over the past quarter, though year-to-date performance is up 22.54%. Short-term trend indicators are bearishly aligned (SMA20 -6.84%, SMA50 1.09%, SMA200 1.55%). The stock’s 14-day RSI is 46.92 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -50.9% below its high and over 104.62% above its low. Average 10-day trading volume of 312.09 thousand shares is below the 3-month average of 590.18 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Hyperfine, Inc. (NASDAQ:HYPR) closed at $1.09 USD, losing -$0.01 (-0.91%) from the previous close of $1.10. The stock is currently mid-range between its 52-week high and low $0.53 and $2.22. With a market capitalization of about $83.05 million, Hyperfine, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.09). Key stats such as the average daily volume over the past year has been around 603.58 thousand shares, volume is running light vs its 52-week average. Headquartered in Guilford, CT, Hyperfine, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Maria Degois-Sainz, the company employs approximately 111 people and listed since January 28, 2021. Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products.

Hyperfine, Inc. has 63.53 million shares outstanding. The public float is 59.28 million shares, elevated short interest at 3.63% of float. This equals 2.22 million shares. The short ratio is 3.78 days. Institutional investors hold 15.5% of the float. Insiders own 6.67%. HC Sponsor LLC holds 1.25 million shares, ROTHBERG JONATHAN M has 885.71 thousand shares and TEISSEYRE THOMAS has 379.66 thousand shares. Over the past six months, insider transactions show net selling. They sold 2.56 thousand shares across 2 transactions.

Hyperfine, Inc. trades at a P/E ratio of -2.18, slightly below the S&P 500 average, with a price-to-sales ratio of 7.95 and a price-to-book ratio of 3.25 trading at moderately above to book value. The P/FCF stands at -2.61, also above market averages.

Hyperfine, Inc. (NASDAQ:HYPR) shares are up 22.54% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Hyperfine, Inc. trading at a premium to the broader market with a P/E of -2.18. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $2.90, suggesting 166.06% upside. Our AI forecast model points to short-term strength (6.42% over two weeks), a medium-term fall (-65.14% over three months), and a longer-term gain (1194.5% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Hyperfine, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.42%, with price expected at $1.16 by February 25, 2026, within a range of $1.05 to $1.26 3-Month Outlook: Projected fall of -65.14%, reaching $0.38 by May 12, 2026, with a range of $0.31 to $0.43. 1-Year Outlook: Projected gain of 1194.5%, with price at $14.11 by February 11, 2027, within a range of $12.24 to $18.10.